Cannara Biotech Inc. has announced the extension and related amendments to its existing credit agreement with the Bank of Montreal and convertible debenture originally issued on June 21, 2021, as amended on August 31, 2023, and January 30, 2024, in the total initial principal amount of $5.7 million to Olymbec Investments Inc., designed to optimize the company’s financial position and enhance its ability to execute its long-term strategy.

Cannara Biotech Inc., a client of our Bristol Investor Relations firm in Canada, is a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices.

Read the full press release here: Cannara Announces Extension of BMO Credit Facility and Convertible Debenture to Enhance Financial Flexibility and Support Execution of its Long-Term Strategy